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Background
During the past years an E coli clonal lineage ST131 has
emerged explosively, causing predominantly community-
onset antimicrobial resistant infections. E coli ST131 has
been shown to harbor a number of virulence and resis-
tance genes and is now recognized for its ability to cause
potentially severe infections in many parts of the develop-
ing world, implying public health measures in attempt to
control infection.
Methods
Eighty-five drug-resistant E coli isolates from patients
with blood stream infections (BSI) were screened by a
ST131-clone allele-specific PCR for the pabB gene and
analyzed for genes encoding ESBL by PCR and sequen-
cing. Integrons were detected by PCR targeting the inte-
grase gene. Gene cassette PCR was conducted on all class
1 integrase-positive isolates. BSI were classified according
to the setting of infection: community acquired (CA),
healthcare-associated (HCA), and hospital acquired (HA).
Results
The sources of E coli BSI, were: urinary in 50 (59%),
gastrointestinal in 9 (11%), respiratory in 4 (5%), other
(including skin and soft tissue) in 3 (3%), unknown in
19 (22%) patients. By pabB PCR, we identified 22 (26%)
E coli isolates belonging to the O25b-ST131 clonal lineage.
Among 22 ST131 E coli isolates, 6 (27%) were from CA,
11 (50%) were from HCA, and 5 (23%) were from HA
infections, while among 61 non-ST 131 E coli isolates,
30 (49%) were from CA, 14 (23%) were from HCA, and
17 (28%) from HA infections (p=0.053). ESBL genes were
found in 20 (91%) ST131 and 13 (21%) non-ST131 E coli
isolates (p<0.0001, OR=38.46 [95%CI: 7.95-186.06]). The
ST131 isolates carried blaCTX-M in 18 (82%), blaTEM-1 in
6 (27%) and blaOXA-1 in 18 (82%). Class I integrons were
identified in 11 (50%) ST131-producing E coli strains and
36 (57%) non-ST131 E coli strains (p=0.623, OR=0.750
[95%CI: 0.283-1.9850]). Resistance to trimethoprim/sulfa-
methoxazole was found in 11 (50%) ST131 E coli isolates
and in 32 (59%) non-ST131 E coli strains (p=0.610), while
resistance to both fluoroquinolones and aminoglycosides
was identified in 18 (82%) ST131 E coli isolates compared
to 10 (16%) non-ST131 E coli strains (p<0.001). Among
patients with BSI caused by resistant E coli, the in-hospital
mortality was similar in patients infected with strains car-
rying the ST131 clonal lineage (3; 14%) versus non ST131
(10; 17%) (p=0.921).
Conclusion
In our study group, BSI caused by E coli ST131 were most
likely to be hospital rather than community associated.
We found more ESBL genes in ST131 E coli isolates, while
class I integrons were present in both groups in similar
rates.
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